Winnergy Medical PCL (BKK:WINMED)

Instructure Holdings Income Statement

Financials in millions THB. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	672	654.36	639.18	703.41	538.64	530.54
Revenue Growth (YoY)	4.88%	2.37%	-9.13%	30.59%	1.53%	7.75%
Cost of Revenue	395.68	386.08	380.75	441.55	295.37	283.2
Gross Profit	276.32	268.27	258.43	261.87	243.27	247.34
Selling, General & Admin	250.15	243.8	221.37	203.68	186.24	177.86
Operating Expenses	250.15	243.8	221.37	203.68	186.24	177.86
Operating Income	26.17	24.47	37.06	58.18	57.03	69.48
Interest Expense	-12.92	-12.17	-9.07	-6.87	-4.94	-8.05
Interest & Investment Income	2.33	2.66	4.68	16.1	17.56	0
Currency Exchange Gain (Loss)	1.75	1.14	0.83	-	-	-
Other Non Operating Income (Expenses)	3.72	1.12	1.76	1.66	0.78	0.51
EBT Excluding Unusual Items	21.05	17.22	35.25	69.07	70.44	61.94
Gain (Loss) on Sale of Assets	12.19	12.19	-	-	-	-
Other Unusual Items	4.57	4.57	-	0.45	1.73	-
Pretax Income	37.8	33.97	35.25	69.52	72.16	61.94
Income Tax Expense	5.51	4.71	4.61	8.85	6.96	10.35
Net Income	32.29	29.26	30.64	60.67	65.21	51.59
Net Income to Common	32.29	29.26	30.64	60.67	65.21	51.59
Net Income Growth	17.32%	-4.50%	-49.50%	-6.96%	26.39%	13.96%
Shares Outstanding (Basic)	400	400	400	400	359	163
Shares Outstanding (Diluted)	400	400	400	400	359	163
Shares Change (YoY)	-	-	-	11.55%	119.55%	48.48%
EPS (Basic)	0.08	0.07	0.08	0.15	0.18	0.32
EPS (Diluted)	0.08	0.07	0.08	0.15	0.18	0.32
EPS Growth	17.32%	-4.50%	-49.50%	-16.59%	-42.43%	-23.24%
Free Cash Flow	-103.27	-67.37	-46.1	-131.78	-48.66	-30.82
Free Cash Flow Per Share	-0.26	-0.17	-0.12	-0.33	-0.14	-0.19
Dividend Per Share	0.025	0.025	0.029	0.057	0.065	0.149
Dividend Growth	-16.10%	-16.10%	-48.16%	-12.46%	-56.35%	-98.18%
Gross Margin	41.12%	41.00%	40.43%	37.23%	45.16%	46.62%
Operating Margin	3.89%	3.74%	5.80%	8.27%	10.59%	13.10%
Profit Margin	4.81%	4.47%	4.79%	8.63%	12.11%	9.72%
Free Cash Flow Margin	-15.37%	-10.29%	-7.21%	-18.73%	-9.03%	-5.81%
EBITDA	67.83	65.05	75.7	93.15	82.45	86.82
EBITDA Margin	10.09%	9.94%	11.84%	13.24%	15.31%	16.36%
D&A For EBITDA	41.66	40.58	38.64	34.96	25.41	17.34
EBIT	26.17	24.47	37.06	58.18	57.03	69.48
EBIT Margin	3.89%	3.74%	5.80%	8.27%	10.59%	13.10%
Effective Tax Rate	14.57%	13.88%	13.09%	12.73%	9.64%	16.71%
Revenue as Reported	672	654.36	639.18	703.41	538.64	530.54
Advertising Expenses	-	17.18	17.26	18.95	12.5	10.63

Source: S&P Global Market Intelligence. Standard template. Financial Sources.